Lv11
64 积分 2021-11-20 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
20天前
已完结
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
1个月前
已完结
A Comparison of Murine PD-1 and PD-L1 Monoclonal Antibodies
2个月前
已关闭
Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis)
2个月前
已完结
Interleukin-2-induced hepatic injury involves temporal patterns of cell adhesion in the microcirculation
2个月前
已完结
Blockade of Hyaluronan Inhibits IL-2-Induced Vascular Leak Syndrome and Maintains Effectiveness of IL-2 Treatment for Metastatic Melanoma
2个月前
已完结
Role of asialo-GM1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice
2个月前
已完结
Deep insight into cytokine storm: from pathogenesis to treatment
2个月前
已完结
Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study
2个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2个月前
已完结
皖公网安备34019202002308
